Results 41 to 50 of about 1,029,114 (257)

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

open access: yesMolecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq   +8 more
wiley   +1 more source

Partial FAK suppression promotes tumor growth, an effect reversed by macrophage p110δ PI3K inactivation

open access: yesMolecular Oncology, EarlyView.
Partial inhibition of focal adhesion kinase (FAK) can paradoxically promote tumor growth, rather than simply producing a weaker antitumor effect than that observed with strong FAK suppression. In breast cancer and melanoma models, targeting p110δ PI3K, particularly in macrophages, counteracted these tumor‐promoting effects, highlighting the importance ...
Lydia Xenou   +4 more
wiley   +1 more source

Prediction uncertainty estimates elucidate the limitation of current NSCLC subtype classification in representing mutational heterogeneity

open access: yesScientific Reports
The heterogeneous pathogenesis and treatment response of non-small cell lung cancer (NSCLC) has led clinical treatment decisions to be guided by NSCLC subtypes, with lung adenocarcinoma and lung squamous cell carcinoma being the most common subtypes ...
Andrei Puiu   +5 more
doaj   +1 more source

Unleashing Green Innovation in Enterprises: The Transformative Power of Digital Technology Application, Green Human Resource, and Digital Innovation Networks

open access: yesSystems, 2023
The rapid development of digital technology has injected new vitality into green technological innovation within manufacturing enterprises. Proper application of digital technology during the innovation process can propel global sustainable development ...
Jian Liu, Qibin Wang, Chaoyi Wei
doaj   +1 more source

Humanization of digital technologies

open access: yesHuman Technology
This editorial introduces the special issue arising from the "11th International Conference on Communities and Technologies - Humanisation of Digital Technologies". It sets the stage for a series of papers that illustrate a shift from technology-centred to human-centred approaches in the development of digital technologies. The editorial highlights the
Siemon Dominik, Wolff Annika
openaire   +2 more sources

Profiling neoadjuvant therapy response in rectal cancer using meta‐analysis of publicly available transcriptomic RNA‐seq datasets

open access: yesMolecular Oncology, EarlyView.
This study integrates publicly available transcriptomic datasets to identify molecular signatures associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. By analyzing a combination of multiple cohorts with bioinformatics approaches, we reveal biological pathways and immune‐related features that may improve ...
Aleksandra Stanojevic   +10 more
wiley   +1 more source

Digital ureteroscopes: technology update

open access: yesResearch and Reports in Urology, 2017
Chad M Gridley, Bodo E Knudsen Department of Urology, The Ohio State University Wexner Medical Center, Columbus, OH, USA Abstract: The field of ureteroscopy has undergone a continual evolution since the first ureteroscopes were introduced.
Gridley CM, Knudsen BE
doaj  

Hybrid neural network for personnel recognition and tracking in remote bidding evaluation monitoring

open access: yesScientific Reports
Unauthorized access to the bidding evaluation office and the departure of experts can significantly compromise the quality of on-site assessment work and introduce substantial integrity risks.
Zhihao Zhou   +6 more
doaj   +1 more source

Telehealth and Digital Technology

open access: yesTelehealth and Medicine Today, 2018
No abstract available. Editor’s note: This is the first in a series of articles by Dr. Englander that will discuss different elements of the value chain—where we are today, where there are gaps, and what the most innovative companies are doing to ...
Libbe Englander
doaj   +1 more source

SPHINX31 acts as a SRPK1 inhibitor targeting the ATR/DNA‐PKcs/CHK1 replicative checkpoint to inhibit cell growth in non‐small cell lung cancer

open access: yesMolecular Oncology, EarlyView.
The kinase SRPK1 directly interacts with the protein TOPBP1 and regulates the pre‐mRNA splicing of WIZ thereby contributing to the activation of the ATR/CHK1 replicative checkpoint in response to replicative stress. This allows cancer cells' genomic stability and survival.
Amani Shreim   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy